Mestastop raised $500K Pre-Series A funding from 92 Angels, Malpani Ventures

Pre-Series A round led by 92 Angels and Malpani Ventures raised Rs 4.5 crore ($500k) for Mestastop Solutions.

The company received a seed investment of Rs 2 crore in 2021 from IIM Ahmedabad’s CIIE, with participation from IKP and angel investors.

By identifying likely clinical candidates, the funds will be used to advance drug repurposing efforts to delay metastasis as well as to produce proof of concept data with small molecules around the identified targets. Along with strategic business development initiatives, the company says new animal models and clinical studies will also be supported.

Arnab and Debabani Roy Chowdhury founded Mestastop, a platform that focuses on cancer metastasis and uses wet lab biology and predictive analytics to identify and distinguish specific metastasis properties and use them for drug discovery and patient treatment.

This year, Malpani Ventures has invested in two startups: Bengaluru-based Nexxio and cloud computing developer Selligion Technologies.